Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity. - Wikidata - awgldk - TriplyDB

Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.

Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.

http://www.wikidata.org/entity/Q37323685

about

Breaking tolerance to thyroid antigens: changing concepts in thyroid autoimmunity Evolution of animal models in cancer vaccine development The role of regulatory T cells in cancer.Opportunistic Autoimmune Disorders Potentiated by Immune-Checkpoint Inhibitors Anti-CTLA-4 and Anti-PD-1 Anti-HER2 vaccines: new prospects for breast cancer therapy Vaccines and immunotherapeutics for the treatment of malignant disease Immunotherapeutic intervention with oncolytic adenovirus in mouse mammary tumors.Cancer stem cell vaccination confers significant antitumor immunity Preclinical HER-2 Vaccines: From Rodent to Human HER-2 Intratumoral DNA electroporation induces anti-tumor immunity and tumor regression.Reduced skin homing by functional Treg in vitiligo.Opportunistic autoimmune disorders: from immunotherapy to immune dysregulation Autoimmune thyroiditis as an indicator of autoimmune sequelae during cancer immunotherapy.Enhanced autoimmunity associated with induction of tumor immunity in thyroiditis-susceptible mice.Scutellaria extract and wogonin inhibit tumor-mediated induction of T(reg) cells via inhibition of TGF-β1 activity.Combining human and rat sequences in her-2 DNA vaccines blunts immune tolerance and drives antitumor immunity.Preclinical vaccines against mammary carcinoma.RNA interference-mediated silencing of Foxo3 in antigen-presenting cells as a strategy for the enhancement of DNA vaccine potency.West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.Homology, similarity, and identity in peptide epitope immunodefinition.Thyroid Autoantibodies Display both “Original Antigenic Sin” and Epitope Spreading.Therapeutic blockade of Foxp3 in experimental breast cancer models.DNA vaccines for prostate cancer.

P2860

Q26852013-4651CB34-615E-4EAC-A056-2CBFCE94EB3E Q28080739-63691B9B-93F2-4260-9A59-A89B8C5470CB Q33631986-8E71B3B4-BFFC-422C-A629-5633587F1FA7 Q33658400-625EC109-0B9E-494E-8BA9-C5995E9E269C Q34105959-101D3577-4288-4DB3-9995-6CD20CBD87D9 Q34170074-49F25EA0-DBFB-4154-9E01-12BFC7A624BC Q35201826-99DCD01D-7D86-4240-B7CC-55A752BCA613 Q35873918-3DB1E233-5B58-4EB6-9FEF-EB5DE2B84210 Q36914661-3D1087B2-0792-445A-9733-99979001F25A Q36984725-E7F72AA7-6257-4B0C-8DD5-5985C4569F6D Q37187413-5D53CA4D-5E38-4B98-BE3B-6DE95A317A61 Q37274049-21814535-9EC2-4C3A-AD1C-91CF86F42EFE Q37388149-BD15C131-024A-49E6-8A76-EFA16CC041EC Q37404065-CBD77AEE-7767-445F-AAF8-5EFB04EA97A7 Q37520219-728E74EC-813D-4379-B04B-6A7B3B970E03 Q37626805-337D0B7C-30D6-47BD-AA14-E0EDE4FB8878 Q38160252-180B7B08-38D7-491A-9691-4109531249BC Q39627674-C2589E2A-8E96-4AAE-8CCD-639F03ABB0E7 Q40269573-1DBA1772-D30B-42D7-9846-71F1F3E8C91F Q43487466-A608E03B-9E12-42E0-8B83-2FC38ACD30DE Q47412579-1EC97AE0-A086-4A24-A4D5-6BE14E236363 Q48325267-DB838B17-2CC5-46BF-BF57-63EE760B855B Q51142505-6A9DE1BB-F9C9-46D5-B77E-7644D73247C0

P2860

Tumor regression following DNA vaccination and regulatory T cell depletion in neu transgenic mice leads to an increased risk for autoimmunity.

http://www.wikidata.org/entity/Q37323685

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on May 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tumor regression following DNA ...... creased risk for autoimmunity.

@en

Tumor regression following DNA ...... creased risk for autoimmunity.

@nl

type

label

Tumor regression following DNA ...... creased risk for autoimmunity.

@en

Tumor regression following DNA ...... creased risk for autoimmunity.

@nl

prefLabel

Tumor regression following DNA ...... creased risk for autoimmunity.

@en

Tumor regression following DNA ...... creased risk for autoimmunity.

@nl

P1433

Q37323685-AF894C64-F4CC-4F60-8C17-1B527B1D979F

P1476

Q37323685-FABBB207-04D9-4660-814A-E6CADC715027

P2093

Q37323685-38B2DF8F-E87C-43E0-B390-44F8D690480C

Q37323685-735B2088-2519-47E8-B643-F4AD9B7C3485

Q37323685-C025ADC6-9BA0-4B47-AB5D-B72F449DFA9F

Q37323685-E6C5409B-A04A-4470-ABC4-7BE897EB1A73

Q37323685-F8397C5B-C87F-4056-A981-C7B4A5387CE2

P2860

Q37323685-00A02F1F-5017-43DB-8751-3308D6A8350B

Q37323685-1823E096-D237-43AD-82FA-F5FCE87CAB97

Q37323685-310499F8-D1E2-49D4-87BB-5A04D706D314

Q37323685-35301CF7-7605-412C-96F6-5A8F83799244

Q37323685-378E8EE5-45FB-40C5-86D8-14D3D06B04B2

Q37323685-510256DD-67B4-44BC-A451-E9B3640C97FA

Q37323685-523D9878-6D83-46C4-B63B-79195D4FEEC7

Q37323685-54ED0318-FB25-41DA-AAE8-B8EC84BB54B4

Q37323685-730F9FB8-2DFE-45B1-8154-940BADCCAE0E

Q37323685-870C6F2A-231E-4CDE-992B-F8D6748230C4

P304

Q37323685-059216E0-CF12-4E6C-A164-7D872EFC71F1

P31

Q37323685-281C2A0B-99B7-4613-A1A5-A515D3B2B43C

P356

Q37323685-3FB32ADD-5671-4EF1-AC34-261E62D82F1E

P407

Q37323685-3D0CF6E7-2FBE-4CCF-87FB-4893EB7AC4FD

P433

Q37323685-F235F45E-B61B-435A-8858-6DCEC6493568

P478

Q37323685-706FA52F-9E63-4369-BAED-53915A726601

P577

Q37323685-4C940A0A-5FA2-49D3-96B2-A96CA001DF39

P5875

Q37323685-93C6300F-4C29-48CF-8A7D-B8FD346DE100

P698

Q37323685-A2F5560C-C206-4C53-AEEC-2E819766A7AB

P932

Q37323685-7F42496A-D15F-4197-898E-AF0D29738F4C

P356

JIMMUNOL.0804074

P1433

Journal of Immunology

P1476

Tumor regression following DNA ...... creased risk for autoimmunity.

@en

P2093

Daniel P Snower

http://www.w3.org/2001/XMLSchema#string

Ilke Nalbantoglu

http://www.w3.org/2001/XMLSchema#string

Jennifer B Jacob

http://www.w3.org/2001/XMLSchema#string

Wei-Zen Wei

http://www.w3.org/2001/XMLSchema#string

Yi-chi M Kong

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma

Epidemiology and estimated population burden of selected autoimmune diseases in the United States.

Analysis of the cellular mechanism of antitumor responses and autoimmunity in patients treated with CTLA-4 blockade.

From breast cancer immunobiology to her-2 DNA vaccine and autoimmune sequelae.

Cytotoxic T-lymphocyte-associated antigen-4 blockage can induce autoimmune hypophysitis in patients with metastatic melanoma and renal cancer.

Tolerance to autoimmune thyroiditis: (CD4+)CD25+ regulatory T cells influence susceptibility but do not supersede MHC class II restriction.

HLA-DRB1 polymorphism determines susceptibility to autoimmune thyroiditis in transgenic mice: definitive association with HLA-DRB1*0301 (DR3) gene

Interleukin 12-mediated prevention of spontaneous mammary adenocarcinomas in two lines of Her-2/neu transgenic mice.

Genetic regulation of the response to Her-2 DNA vaccination in human Her-2 transgenic mice.

Regulation of autoimmune response to mouse thyroglobulin: influence of H-2D-end genes.

P304

5873-5881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4049/JIMMUNOL.0804074

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

182

http://www.w3.org/2001/XMLSchema#string

P577

2009-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

24311689

http://www.w3.org/2001/XMLSchema#string

P698

19380836

http://www.w3.org/2001/XMLSchema#string

P932

3833444

http://www.w3.org/2001/XMLSchema#string